2024
Using Neuromodulators for Salivary, Eccrine, and Apocrine Gland Disorders
Rajanala S, Salame N, Dover J. Using Neuromodulators for Salivary, Eccrine, and Apocrine Gland Disorders. Dermatologic Surgery 2024, 50: s103-s111. PMID: 39196843, DOI: 10.1097/dss.0000000000004262.Peer-Reviewed Original ResearchConceptsQuality of lifeParasympathetic cholinergic neuronsBotulinum toxinLong-term treatmentPatients' quality of lifeTreatment of sialorrheaBotulinum toxin serotype ABotulinum toxin treatmentToxin serotype AImpact patient healthStandard doseGlandular disordersOff-labelOnabotulinumtoxin AIncobotulinumtoxin AAxillary hyperhidrosisNoninvasive treatmentPatient healthApplication of neuromodulationCholinergic neuronsPatients' qualityApocrine glandsHyperhidrosisSerotype BToxin treatment
2020
Physical Activity After Treatment for Symptomatic Peripheral Artery Disease
Peri-Okonny PA, Patel S, Spertus JA, Jackson EA, Malik AO, Provance J, Mena-Hurtado C, Shishehbor MH, Hijjaji V, Gosch KL, Smolderen K. Physical Activity After Treatment for Symptomatic Peripheral Artery Disease. The American Journal Of Cardiology 2020, 138: 107-113. PMID: 33065083, PMCID: PMC7736254, DOI: 10.1016/j.amjcard.2020.10.011.Peer-Reviewed Original ResearchMeSH KeywordsAgedAnkle Brachial IndexConservative TreatmentEndovascular ProceduresExerciseExercise TherapyFemaleHealth StatusHumansHydroxymethylglutaryl-CoA Reductase InhibitorsIntermittent ClaudicationLeisure ActivitiesLinear ModelsLogistic ModelsMaleMiddle AgedMultivariate AnalysisPatient SatisfactionPeripheral Arterial DiseasePlatelet Aggregation InhibitorsQuality of LifeSedentary BehaviorSmoking CessationSocial InteractionVascular Surgical ProceduresWorkConceptsPhysical activity levelsPhysical activityInvasive treatmentSymptomatic peripheral artery diseasePeripheral artery diseaseMultivariable logistic regressionAssociation of treatmentActivity levelsMultivariable linear regressionHealth status changesHealth status gainsPAD outcomesArtery diseaseVascular clinicInvasive groupNoninvasive treatmentHealth statusLogistic regressionActivity statusLTPAClaudicationTreatmentPatientsStatus changesAssociation
2017
Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians.
Qaseem A, Wilt T, McLean R, Forciea M, Denberg T, Barry M, Boyd C, Chow R, Fitterman N, Harris R, Humphrey L, Vijan S. Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians. Annals Of Internal Medicine 2017, 166: 514-530. PMID: 28192789, DOI: 10.7326/m16-2367.Peer-Reviewed Original ResearchConceptsChronic low back painLow back painNonsteroidal anti-inflammatory drugsBack painAnti-inflammatory drugsNonpharmacologic treatmentsPharmacologic treatmentPatient populationSpinal manipulationAmerican CollegeNoninvasive treatmentSystematic reviewLow-level laser therapySecond-line therapyBack pain episodesFirst-line therapyHealth-related qualityMotor control exercisesClinical practice guidelinesTarget patient populationSkeletal muscle relaxantsMindfulness-based stress reductionCognitive behavioral therapyNonpharmacologic therapiesPain episodes
2013
Dendrimer Advances for the Central Nervous System Delivery of Therapeutics
Xu L, Zhang H, Wu Y. Dendrimer Advances for the Central Nervous System Delivery of Therapeutics. ACS Chemical Neuroscience 2013, 5: 2-13. PMID: 24274162, PMCID: PMC3894720, DOI: 10.1021/cn400182z.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsBlood-brain barrierCNS therapeutic agentsDendrimer-mediated deliveryTherapeutic agentsCentral nervous system diseaseTreatment of CNSCentral nervous system deliveryNervous system diseasesMost CNS drugsBrain parenchymaSystem diseasesBrain tumorsCNS drugsNoninvasive treatmentCNS therapeuticsPoor accessDeliveryTreatmentTherapeuticsAgentsSystem deliveryTumorsCNSDiseaseDiagnosis
2007
Management of nonmelanoma skin cancer in 2007
Neville JA, Welch E, Leffell DJ. Management of nonmelanoma skin cancer in 2007. Nature Reviews Clinical Oncology 2007, 4: 462-469. PMID: 17657251, DOI: 10.1038/ncponc0883.Peer-Reviewed Original ResearchConceptsNonmelanoma skin cancerSkin cancerNew noninvasive treatmentImmune response modifiersMohs micrographic surgeryTopical chemotherapeuticsSelect tumorsHistological patternMicrographic surgerySurgical methodsConventional excisionNoninvasive optionNoninvasive treatmentTumor typesSurgeryCancerPhotodynamic therapyTreatmentCurettageMorbidityElectrodesiccationTherapyTumorsExcisionRetinoids
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply